-

STEMCELL Technologies Releases “Toward Sustainable Science” Report

VANCOUVER, British Columbia--(BUSINESS WIRE)--STEMCELL Technologies, Canada’s largest biotechnology company, is releasing its first annual sustainability report today. The report, entitled Toward Sustainable Science, provides a comprehensive look at STEMCELL’s environmental, social, and governance performance over the company’s 2023 Fiscal Year (July 1, 2022 through June 30, 2023).

“As a company of Scientists Helping Scientists, we know we have a leadership role to play in protecting the environment and that means embedding sustainability into all our decision-making,” said Dr. Allen Eaves, President and CEO, STEMCELL. “This report provides important visibility into STEMCELL’s business practices, including what steps we have taken this past year to reduce our environmental impact and how we are supporting the communities in which we live and work.”

Highlights of the report include:

  • ISO 14001 recertification of STEMCELL’s Environmental Management System
  • Successful diversion of 39% of waste from landfills – a 14% increase from the previous year
  • More than 4,000 participants in numerous educational outreach initiatives working to increase diversity in science, technology, engineering, and math (STEM)

This past year, STEMCELL also joined the UN Global Compact, the world’s largest corporate sustainability initiative. This includes a commitment to supporting the United Nations Sustainable Development Goals and upholding the Ten Principles on human rights, labor, environment, and anti-corruption.

“In addition, STEMCELL is taking meaningful actions centered around Diversity, Equity, and Inclusion, including building relationships with suppliers, customers, and partners informed by STEMCELL’s dedication to the health and well-being of both the environment and people,” said Dr. Eaves. “STEMCELL is also giving back to our communities through supporting environmental conservation, cancer research, and education programs that inspire the next generation of scientists and science-related professionals.”

To learn more, read Toward Sustainable Science.

About STEMCELL Technologies

STEMCELL Technologies supports life sciences research with more than 2500 specialized reagents, tools, and services. STEMCELL offers high-quality cell culture media, cell separation technologies, instruments, accessory products, educational resources, and contract assay services that are used by scientists performing stem cell, immunology, cancer, regenerative medicine, and cellular therapy research globally.

Contacts

Media Contact
For more information and to arrange an interview, contact:
Ryan-Sang Lee
Senior Manager, Corporate Communications, STEMCELL Technologies
public.relations@stemcell.com

STEMCELL Technologies



Contacts

Media Contact
For more information and to arrange an interview, contact:
Ryan-Sang Lee
Senior Manager, Corporate Communications, STEMCELL Technologies
public.relations@stemcell.com

Social Media Profiles
More News From STEMCELL Technologies

STEMCELL Technologies Introduces STEMprep™ Tissue Dissociator System to Accelerate Research Discoveries

VANCOUVER, British Columbia--(BUSINESS WIRE)--To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. “Tissue dissociation is incredibly important for making advancements in research fields, like cancer and immunology, yet this man...

STEMCELL Technologies Announces Acquisition of Cellular Highways

VANCOUVER, British Columbia & CAMBRIDGE, England--(BUSINESS WIRE)--STEMCELL Technologies, Canada’s largest biotechnology company, is pleased to announce the acquisition of Cellular Highways Ltd from TTP Group Ltd. Cellular Highways is a biotechnology company based near Cambridge, United Kingdom, that specializes in advanced cell sorting technologies with applications in cell and gene therapy, drug discovery, and general cell research, especially where cells are fragile. The acquisition includes...

STEMCELL Launches Novel Cell-Engineering CellPore™ Transfection System

VANCOUVER, British Columbia--(BUSINESS WIRE)--STEMCELL Technologies has commercially launched the CellPore™ Transfection System, providing a groundbreaking new technology with the potential to advance cell engineering research and the development of novel cell therapies to cure diseases. The CellPore™ Transfection System represents a substantial leap forward for cell engineering researchers, offering a novel method—known as mechanoporation—for cargo delivery into mammalian cells. Unlike traditi...
Back to Newsroom